Saving $500 on a $6,000 purchaseis obviously not as good as saving $100 on $4,500, but does yourPBM evaluation process recognize that?

For many health benefit plan sponsors and their advisors, theevaluation process used to compare pharmacy benefits managers(PBMs) keeps drug costs higher than they should be by measuringtheir value with metrics that reward rebates rather than net costs.An RFP process that "spreadsheets" acquisition discounts, rebatesper prescription, and administration costs typically lacks theinformation that plan sponsors need to recommend the option withthe lowest overall costs and doesn't account for utilizationmanagement or improved clinical outcomes.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.